MoneyWorks4Me

Desh Rakshak Aushdhalaya submits statement of deviation

28 Apr 2020 Evaluate

Desh Rakshak Aushdhalaya has informed about submission of Statement of Deviation or Variation In Public Issue, Right Issue, Preferential Issue, etc, pursuant to Regulation 32(1) of SEBI (LODR) Regulations, 2015 for the purpose of making disclosure to the Stock Exchange.

The above information is a part of company's filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1844.90
Dr. Reddys Labs. 1217.35
Cipla 1391.95
Lupin 2065.00
Zydus Lifesciences 1223.95
View more..